HDAC9 and cancer: It has been reported that the transcriptional result of HDAC inhibition is generally pro-apoptotic and anti-proliferative [139] so cancer cells may have adapted mechanisms to counteract the HDAC-inhibitory activities of these oncometabolites which accumulate intracellularly and extracellularly.